Informação sobre produto
Nome:
Revatropate
Sinónimos:
- (3R-(3R*(S*(R*))))-1-Azabicyclo(2.2.2)oct-3-yl alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)benzenacetate
- (R)-3-Quinuclidinyl (S)-beta-hydroxy-alpha-(2-(R)-methylsulfinyl)ethyl)hydratropate
- Uk-112,166
- Unii-3W7L15V40W
- Benzenacetic acid, alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)-, 1-azabicyclo(2.2.2)oct-3-yl ester, (3R-(3R*(S*(R*))))-
- (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate
Descrição:
Revatropate is a chiral compound that belongs to the class of antimuscarinic drugs. It is used to treat motility disorders such as constipation, diarrhea, and irritable bowel syndrome. Revatropate has been shown to have high activity against syncytial virus infections and inflammatory bowel disease. This drug also inhibits the synthesis of phospholipase A 2 , which has been implicated in the pathogenesis of autoimmune diseases. The molecular mechanism for this effect is not known, but it may be due to the inhibition of water vapor loss from the bladder by reducing ileal motility.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
365.49 g/mol
Fórmula:
C19H27NO4S
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
